GR1003636B - Ισχυροααντιπηκτικοακαιααντιαιμοπεταλικοαφαρμακοαγιαατηναισχαιμικηακαρδιοπαθειαα - Google Patents
ΙσχυροααντιπηκτικοακαιααντιαιμοπεταλικοαφαρμακοαγιαατηναισχαιμικηακαρδιοπαθειααInfo
- Publication number
- GR1003636B GR1003636B GR20000100148A GR2000100148A GR1003636B GR 1003636 B GR1003636 B GR 1003636B GR 20000100148 A GR20000100148 A GR 20000100148A GR 2000100148 A GR2000100148 A GR 2000100148A GR 1003636 B GR1003636 B GR 1003636B
- Authority
- GR
- Greece
- Prior art keywords
- inhibition
- allium sativum
- relates
- factors
- activation
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title 2
- 230000000702 anti-platelet effect Effects 0.000 title 1
- 229940127219 anticoagulant drug Drugs 0.000 title 1
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
- 230000003389 potentiating effect Effects 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 240000002234 Allium sativum Species 0.000 abstract 4
- 239000000284 extract Substances 0.000 abstract 4
- 235000004611 garlic Nutrition 0.000 abstract 4
- 230000005764 inhibitory process Effects 0.000 abstract 4
- 150000003904 phospholipids Chemical class 0.000 abstract 3
- 230000004913 activation Effects 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 abstract 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 102000003790 Thrombin receptors Human genes 0.000 abstract 1
- 108090000166 Thrombin receptors Proteins 0.000 abstract 1
- 229940030225 antihemorrhagics Drugs 0.000 abstract 1
- 239000003114 blood coagulation factor Substances 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- 231100000673 dose–response relationship Toxicity 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000025 haemostatic effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 102000006495 integrins Human genes 0.000 abstract 1
- 108010044426 integrins Proteins 0.000 abstract 1
- 230000006623 intrinsic pathway Effects 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 230000010118 platelet activation Effects 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ΑΗΑπαρούσαΑεφεύρεσηΑαναφέρεταιΑστηΑχρήσηΑτουΑAlliumΑSavitumΑγιαΑτηνΑπαρασκευήΑφαρμακευτικούΑσκευάσματοςΑγιαΑτηνΑπρόληψηΑκαιΑθεραπείαΑτηςΑισχαιμικήςΑκαρδιοπάθειας.ΗΑχρήσηΑαυτήΑπροκύπτειΑαπόΑτηνΑανασταλτικήΑδράσηΑτουΑAlliumΑSativumΑστηνΑενεργοποίησηΑτωνΑπαραγόντωνΑπήξεωςΑ}ενδογενήςΑοδόςBΑοφειλόμενηΑστηνΑαναστολήΑδέσμευσηςΑενεργοποιημένωνΑκαιΑμηΑπαραγόντωνΑπήξεως-ενζύμωνΑσταΑφωσφολιποειδήΑκαιΑστηνΑαναχαίτισηΑδράσηςΑτηςΑφωσφολιπιδικήςΑμεμβράνηςΑσανΑυπόστρωμαΑενεργοποίησηςΑτωνΑπαραγόντωνΑτηςΑπήξεως.ΗΑχρήσηΑαυτήΑπροκύπτειΑεπίσηςΑαπόΑτηνΑαναστολήΑενεργοποίησηςΑτωνΑαιμοπεταλίωνΑοφειλόμενηΑσεΑδοσοεξαρτώμενηΑαναχαίτισηΑέκφρασηςΑτουΑυποδοχέαΑτηςΑθρομβίνηςΑ}χωρίςΑναΑαποκλείονταιΑωστόσοΑκαιΑηΑαπ'ευθείαςΑαναχαίτισηΑτηςΑιντεγκρίνηςΑΙΙb/ΙΙIaBΑκαιΑαναστολήΑδράσηςΑτωνΑαιμοπεταλιακώνΑφωσφολιποειδών.ΜεΑβάσηΑτονΑπαραπάνωΑμηχανισμόΑδράσηςΑηΑχορήγησηΑτουΑσκευάσματοςΑενδείκνυταιΑναΑείναιΑπαρεντερικήΑ}μεΑήΑχωρίςΑσταθεροποιητέςB.ΰ
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20000100148A GR1003636B (el) | 2000-04-25 | 2000-04-25 | Ισχυροααντιπηκτικοακαιααντιαιμοπεταλικοαφαρμακοαγιαατηναισχαιμικηακαρδιοπαθειαα |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20000100148A GR1003636B (el) | 2000-04-25 | 2000-04-25 | Ισχυροααντιπηκτικοακαιααντιαιμοπεταλικοαφαρμακοαγιαατηναισχαιμικηακαρδιοπαθειαα |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1003636B true GR1003636B (el) | 2001-08-02 |
Family
ID=10944261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20000100148A GR1003636B (el) | 2000-04-25 | 2000-04-25 | Ισχυροααντιπηκτικοακαιααντιαιμοπεταλικοαφαρμακοαγιαατηναισχαιμικηακαρδιοπαθειαα |
Country Status (1)
| Country | Link |
|---|---|
| GR (1) | GR1003636B (el) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7588784B2 (en) | 2007-10-05 | 2009-09-15 | Attila Mady | Use of onion extracts to prevent and treat acute and chronic cardiac and vascular complications and their sequelae, as well as to resolve hematomas |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5742620A (en) * | 1980-08-28 | 1982-03-10 | Yakult Honsha Co Ltd | Novel antiulcer agent |
| JPH01221321A (ja) * | 1988-02-26 | 1989-09-04 | Wakunaga Pharmaceut Co Ltd | 脂質過酸化抑制剤 |
| CN1110138A (zh) * | 1994-04-08 | 1995-10-18 | 史载祥 | 治疗心、脑、血管疾病的中药制剂 |
-
2000
- 2000-04-25 GR GR20000100148A patent/GR1003636B/el not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5742620A (en) * | 1980-08-28 | 1982-03-10 | Yakult Honsha Co Ltd | Novel antiulcer agent |
| JPH01221321A (ja) * | 1988-02-26 | 1989-09-04 | Wakunaga Pharmaceut Co Ltd | 脂質過酸化抑制剤 |
| CN1110138A (zh) * | 1994-04-08 | 1995-10-18 | 史载祥 | 治疗心、脑、血管疾病的中药制剂 |
Non-Patent Citations (7)
| Title |
|---|
| CIRCULATION, vol. 98, no. 17 SUPPL., 27 October 1998 (1998-10-27), 71st Scientific Sessions of the American Heart Association;Dallas, Texas, USA; November 8-11, 1998, pages I63 - I64, ISSN: 0009-7322 * |
| DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1993, DAS TANDRA ET AL: "Modification of cytotoxic effects of inorganic arsenic by a crude extract of Allium sativum L. in mice.", XP002157030, Database accession no. PREV199497040147 * |
| DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 27 October 1998 (1998-10-27), BATIREL HASAN F ET AL: "Intravenous allicin (garlic extract) improves pulmonary blood flow and reduces lung ischemia-reperfusion injury in rats.", XP002157031, Database accession no. PREV199900523468 * |
| DATABASE WPI Section Ch Week 198941, Derwent World Patents Index; Class B04, AN 1989-297798, XP002157033 * |
| DATABASE WPI Section Ch Week 199735, Derwent World Patents Index; Class B04, AN 1997-373440, XP002157032 * |
| INTERNATIONAL JOURNAL OF PHARMACOGNOSY, vol. 31, no. 4, 1993, pages 316 - 320, ISSN: 0925-1618 * |
| PATENT ABSTRACTS OF JAPAN vol. 006, no. 114 (C - 110) 25 June 1982 (1982-06-25) * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7588784B2 (en) | 2007-10-05 | 2009-09-15 | Attila Mady | Use of onion extracts to prevent and treat acute and chronic cardiac and vascular complications and their sequelae, as well as to resolve hematomas |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY125150A (en) | Factor vlla inhibitors | |
| WO1995021601A3 (en) | Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof | |
| DK1299383T3 (da) | Sulfonyl-pyrrolidinderivater, der kan anvendes til behandling af neurologiske lidelser | |
| IL145068A0 (en) | The use of glycine betaine to prepare a pharmaceutical composition | |
| DK1047416T3 (da) | Farmaceutiske præparater der omfatter disulfiram til inhibering af angionese | |
| MXPA05012880A (es) | Inhibidores de complemento. | |
| MX2008012224A (es) | Limpiador de aparato dental. | |
| Jessie et al. | Inhibition of human platelet aggregation and membrane lipid peroxidation by food spice, saffron | |
| NO972324L (no) | Orale blandinger inneholdende Ondansetron | |
| PL323490A1 (en) | Tetralinic compounds exibiting acitity against multgiple-drug refractoriness | |
| BR9914215A (pt) | Antagonistas de mglur5 para o tratamento da dor e da ansiedade | |
| BR0013009A (pt) | Uso de antagonistas de cgrp e de inibidores de liberação de cgrp para combate a jatos quentes menopáusicos | |
| DK0946157T3 (da) | Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte | |
| WO2002011747A3 (en) | Transglutaminase for inhibiting angiogenesis | |
| DE69626671D1 (de) | Fusionsproteine bestehend aus gewebefaktor-kunitzdomäne als inhibitoren des faktors viia | |
| GR1003636B (el) | Ισχυροααντιπηκτικοακαιααντιαιμοπεταλικοαφαρμακοαγιαατηναισχαιμικηακαρδιοπαθειαα | |
| BR0115983A (pt) | Uso de sarp-1 para o tratamento e/ou prevenção de escleroderma | |
| BR0008192A (pt) | Emplastros tipo folha | |
| SE9902597D0 (sv) | New use | |
| IS2849B (is) | Notkun á írbesartani til framleiðslunnar á lyfjum sem eru notuð til að fyrirbyggja eða meðhöndla lungnaháþrýsting | |
| Oh et al. | Ginseng total saponin inhibits the dopaminergic depletions induced by methamphetamine | |
| DK0824356T3 (da) | Farmaceutiske sammensætninger til behandling af alkoholafhængighed | |
| WO1999055859A3 (en) | Cd40-interacting and traf-interacting proteins | |
| DE59811153D1 (de) | Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe | |
| WO2000069425A3 (de) | Endoparasitizide synergistische kombination enthaltend cyclischen depsipeptiden und piperazinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |
Effective date: 20161104 |